Remove Big Data Remove Engineer Remove Medicine Remove Pharma Companies
article thumbnail

What’s the next step in big data and AI?

Drug Discovery World

Big data and AI are all the rage. But, beyond these buzzwords and the quantity of data, what’s next for these powerful tools? Troy Groetken says that data has the ability to create personalised, predictive and preventative medicine tailored to individual patients and identified patient groups/populations.

article thumbnail

Synthetic control arms in clinical trials: Making it happen

pharmaphorum

Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinical trials. Can the combined potential of new AI technologies and real-world patient data hold the key to overcoming the challenges in clinical trial design that have historically led to trial failure?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How digital innovation is helping therapeutics to get to market faster

Drug Discovery World

Companies leading the way There are a number of companies leading the charge in applying innovative technologies, particularly artificial intelligence (AI) and machine learning (ML), to the search for new medicines. Digital tech is also helping researchers to find target candidates for some of the most challenging disease areas.

article thumbnail

The DDW Podcast: 2023 in review

Drug Discovery World

In this episode, Kelland shares what she means by the ‘next pandemic’, the lessons learnt from the Covid-19 pandemic, and the role of global health organisations and pharma companies going forward. Dr Pace discusses how precision medicine is already starting to influence standards in clinical trial design. Listen here.